RING Finger Proteins Mediators of Ubiquitin Ligase Activity by Joazeiro, Claudio A.P & Weissman, Allan M
Cell, Vol. 102, 549–552, September 1, 2000, Copyright ª 2000 by Cell Press
RING Finger Proteins: Minireview
Mediators of Ubiquitin
Ligase Activity
with ubiquitination was made in 1998 by Bachmair who
noted that a plant N-end rule E3 shared the RING finger
motif with other proteins implicated in ubiquitination
including the yeast N-end rule E3 (Ubr1p), Hrd1p/Der3p,
Rad18p, and an essential anaphase promoting complex
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(APC) component, Apc11p. This was followed in 1999 byDivision of Basic Sciences
a series of exciting reports from the Conaway, Deshaies,National Cancer Institute
Elledge, Harper, Pan, and Xiong laboratories establish-Bethesda, Maryland 20892
ing that a small noncanonical RING finger protein, Rbx1
(also referred to as ROC1 and HRT1), is an essential
component of SCF (Skp1/cullin-1/F-box protein) E3
complexes and that a complex containing Rbx1 and
Until recently no specific function had been ascribed to Cdc53/cullin-1 (CUL-1) is sufficient to mediate ubiqui-
the RING finger beyond a role in dimerization of several tination in vitro. Rbx1 was also determined to be an
proteins. Over the last year and a half, however, reports integral component of VHL-containing complexes, which
from a number of laboratories studying diverse biologi- have subsequently been shown to have E3 activity (re-
cal processes have led to the realization that RING finger viewed in Deshaies, 1999; Tyers and Jorgensen, 2000).
proteins play critical roles in mediating the transfer of The activity of the yeast N-end rule E3, Ubr1, was also
ubiquitin (Ub) both to heterologous substrates as well dependent on its RING finger (Xie and Varshavsky,
as to the RING finger proteins themselves. As RING 1999). c-Cbl was shown to promote the ubiquitination
fingers are found in hundreds of proteins, the number of activated receptor protein tyrosine kinases (RPTKs)
of candidate Ub protein ligases (E3s) has now increased in a RING finger–dependent manner (Waterman et al.,
dramatically. 1999 and references therein) and subsequently deter-
Protein ubiquitination begins with the formation of a mined to have the intrinsic capacity to ubiquitinate
thiol-ester linkage between the C terminus of Ub and RPTKs in vitro in an SH2- and RING finger–dependent
the active site cysteine (Cys) of the Ub activating enzyme manner. Additionally, the bacterially expressed c-Cbl
(E1). Ub is then transferred to an Ub conjugating enzyme RING alone bound E2s and mediated ubiquitination
(Ubc or E2), again through a thiol-ester linkage. E3s, (Joazeiro et al., 1999; Levkowitz et al., 1999; Yokouchi
which are primarily responsible for providing specificity et al., 1999). Similarly, the E3 activity of Mdm2 toward
to Ub conjugation, interact with E2 and substrate, facili- p53 and itself has now been determined to be due to
tating formation of isopeptide bonds between the C its atypical C-terminal RING (Fang et al., 2000; Honda
terminus of Ub and lysines (Lys) either on a target protein and Yasuda, 2000). A general function for the RING finger
or on the last Ub of a protein-bound multi-Ub chain. in ubiquitination was suggested by the finding that multi-
Initial models for ubiquitination suggested that E3s facil- ple, otherwise unrelated, RING-H2 finger proteins all
itate the direct transfer of Ub from E2 to substrate. How-
ever, some E3s including E6-associated protein (E6-
AP) and other HECT E3s (see below) form thiol-ester
intermediates between the conserved HECT Cys and
Ub as part of the process leading to the formation of
multi-Ub chains on proteins. Multi-Ub chains are potent
targeting signals for protein degradation in proteasomes
(reviewed in Hershko and Ciechanover, 1998).
Eukaryotic genomes encode a single or at most a few
E1s. Substantially more E2s exist, at least 11 in yeast
and over 20 in mammals. The diversity and number of
proteins that are regulated by ubiquitination predicts
the existence of a large number of E3s. However, until
recently relatively few E3s were known. The discovery
of E6-AP as an E3 responsible for human papilloma virus
E6-dependent ubiquitination of p53 led to the identifica-
tion of proteins containing an z350 amino acid region
of homology to the E6-AP carboxyl terminus (HECT do-
main), several of which have now been shown to be Figure 1. Variety of Action of E3s, Proteins that Recognize Specific
E3s. On the other hand, no common structural basis for Substrates and Mediate Ligation of the Latter to Ub- or Ub-like
known non-HECT E3s had been appreciated. However, Proteins
it is now clear that all of these include a RING finger (A) Ubiquitination of active RPTK by Cbl; (B) Ubiquitination of p53
either on the same polypeptide that recognizes sub- by Mdm2 and modification of Mdm2 itself with SUMO-1 or Ub; (C)
Multisubunit SCF-type E3: ubiquitination of substrate and of F boxstrate or as a distinct polypeptide in the context of a
protein subunit; modification of cullin subunit with Nedd8; (D) Ubiq-multi-subunit E3 (Figure 1).
uitination of p53 by the HECT-type E3 ligase E6-AP: dependenceThe first suggestion that RING fingers are associated
on human papilloma virus E6 protein and formation of intermediate
Ub thioester with E3. Abbreviations: Y, tyrosine; K, lysine; S, serine;
C, cysteine; P, phosphate group; z, thiol-ester bond.‡ E-mail: cjoazeiro@hotmail.com (C. A. P. J.); amw@nih.gov (A.M.W.).
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Table 1. RING Finger Proteins with Demonstrated E3 Activity, E2 Binding or Involvement in Ubiquitination
Protein Biological Role Substrates Comments
Hrt1/Roc1/Rbx1a in cell cycle, signaling Sic1, IkBa, b-catenin, component of multisubunit SCF E3 also
SCF E3 Cln1/2, others containing Skp1, cullin, alternative
F box proteins
Rbx1a in VCB-CUL2 E3 transcription, signaling HIF1-a with VHL, component of multisubunit E3 also
Vav* with SOCS containing elongins B and C, CUL2,
and VHL or SOCS proteins
Apc11a cell cycle Pds1, mitotic cyclins component of multisubunit APC E3
Cbl family proteinsa signaling RPTKs negative regulator of RPTKs
Ubr1a ? proteins with E3 ligase for the N-end rule pathway (E3a is
destabilizing N mammalian homolog)
termini, Cup9, Ga
Mdm2a apoptosis, proliferation p53, itself inhibited by p19ARF, MdmX
Sinab transcription, signaling Tramtrack* fly photoreceptor development
Siaha signaling DCC*, Vav* tumor suppressor
Prajala, AO7a, ? ? (AO7 ubiquitinated RING-dependent activity
TRC8a, kf-1a in cells)
NF-X1a transcription ? represses MHC-II expression
BRCA-1a DNA repair, transcription ? RING mutations in familial carcinoma
clAPsa, XIAPa apoptosis inhibitors themselves, degradation induced by apoptotic stimuli
caspases 3 and 7
Vmw110b herpesvirus life cycle CENP-C*, PML*, virus-encoded
DNA-PK*
Rad18b, Rad5b DNA repair ? associate with E2s
PMLb ? itself SUMO-modified binds to Ubc9 (E2 for SUMO)
in vivo
Hrd1/Der3b degradation from ER HMG-CoA polytopic ER membrane protein
reductase*, others
COP1b photomorphogenesis HY5* abundance of COP1 is regulated by light
Parkina, RING-IBR-RING ? ? RING mutations associated with autosomal
familyb juvenile parkinsonism; others in the
family shown to bind E2s
a E3 activity demonstrated; bactivity not demonstrated; *putative substrates.
mediate RING- and E2-dependent ubiquitination of Notably, at least one RING-E2 pair (Rad18p and Rad6p/
Ubc2p) have corresponding residues that are polar andthemselves in vitro. Two RING-HC proteins, the tumor
suppressor, BRCA1, and a protein that mediates the therefore likely interact by hydrogen bonding. Thus, the
nature of the residues in the site of E2-RING interac-proteasomal degradation of the deleted in colorectal
cancer gene product, Siah-1, behaved similarly (Lorick tions may play a significant role in determining RING-
E2 pairs.et al., 1999). Thus, a large number of RING finger proteins
are likely to mediate E2-dependent ubiquitination. While HECT E3s form a thiol-ester with Ub, there is
little evidence for such intermediates involving RINGThe RING Finger: Structure and Function
RING fingers have been defined by the consensus E3s. It is likely that RING fingers mediate ubiquitination
by facilitating the direct transfer of Ub from E2s to targetsequence CX2CX(9–39)CX(1–3)HX(2–3)C/HX2CX(4–48)
CX2C with the Cys and His representing zinc binding Lys. This is consistent with the original model of ubiqui-
tination based on biochemical studies on what is nowresidues. RING fingers are subcategorized into RING-
HC and RING-H2 depending of whether a Cys or His known to be a RING finger E3, E3a. How the RING
facilitates ubiquitination remains to be established.occupies the fifth coordination site, respectively. Struc-
tures of RING-HC fingers show two interleaved zinc There is evidence that the role of the RING finger is not
merely to recruit E2s to the vicinity of proteins to bebinding sites. This is in contrast to the tandem arrange-
ment of zinc binding sites characteristic of zinc fingers ubiquitinated. For example, Ubr1p binds its cognate E2,
Rad6p, predominantly via regions outside the RING, yet(reviewed in Freemont, 2000).
There is substantial evidence for interactions between mutations in this region only weakly reduce E3 activity,
while a RING mutation did not affect binding to E2 orRING fingers and E2s. This is now supported by the
crystallization of the c-Cbl SH2 and RING domains to- substrate, but abolished ubiquitination (Xie and Var-
shavsky, 1999). One possibility is that the RING servesgether with a tyrosine-phosphorylated peptide and an
E2, UbcH7 (Zheng et al., 2000). UbcH7 binds to the RING as an allosteric activator of E2. However, UbcH7 shows
no change in conformation when bound to the c-Cbldomain of c-Cbl through contacts between a groove
within the RING domain of c-Cbl and two loops in the RING. Whether an allosteric modification of the complex
of E2 with Ub occurs on binding to the RING awaitsE2 fold of UbcH7. These loops also provide the site of
interaction between UbcH7 and E6-AP. The interactions determination.
RING Finger Proteins Regulate Diverse Cellularbetween UbcH7 and the c-Cbl RING are largely due to
van der Waals interactions involving hydrophobic resi- Processes: Tip of the Iceberg?
RING finger-containing E3s play pivotal roles in diversedues in UbcH7 and the c-Cbl RING. Interacting residues
in c-Cbl include a tryptophan (Trp) found in a number cellular processes and are implicated in contributing to
disease (Table 1). A role for RING finger proteins in theof active RING proteins, mutation of which abrogates
E2 interaction and E3 activity (Joazeiro et al., 1999). cell cycle has been clearly established. Mitotic cyclins
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are targeted for degradation by ubiquitination mediated provide a molecular explanation for the failure to termi-
nate signaling in cells expressing an oncogenic form ofby the APC (or cyclosome), which includes a small RING
finger protein, Apc11p. The yeast APC consists of at c-Cbl that lacks a complete RING finger (Joazeiro et al.,
1999; Levkowitz et al., 1999; Yokouchi et al., 1999).least 12 essential subunits, including the cullin-family
RING finger E3s also play key roles in the secretorymember, Apc2p. As with other RING fingers proteins,
pathway. Hrd1p is a yeast endoplasmic reticulum (ER)Apc11p mediates its own ubiquitination in vitro but inter-
membrane RING finger protein that functions in qualityestingly also directly and specifically ubiquitinates the
control in the ER through its RING finger-dependent roleAPC substrates cyclin B and securin (Leverson et al.,
in proteasomal degradation of abnormal ER proteins.2000; Gmachl et al., 2000; reviewed in Deshaies, 1999;
Hrd1p also mediates the ubiquitination of the residentTyers and Jorgensen, 2000). The cyclin-dependent ki-
ER membrane protein HMGCoA reductase. Other RINGnase inhibitor Sic1p, G1 cyclins, other cell cycle regula-
finger E3s similarly facilitate disposal of membrane pro-tors, and proteins involved in transcriptional regulation
teins from the ER. bTrCP, an F-box SCF componentare targets for the Rbx1-containing SCF E3s (Figure 1).
that targets b-catenin and IkBa for ubiquitination, alsoTogether with the cullin Cdc53p/CUL-1, Rbx1 forms a
recognizes phosphorylated HIV-encoded Vpu in the ERcore that binds to and activates the E2 Cdc34p. Skp1p
membrane, thereby targeting Vpu-bound CD4 for degra-binds to this core and mediates recruitment of various
dation. This results in an increase in the amount of HIVF-box-containing proteins, which confer substrate speci-
Env available for virus production. Thus, Vpu uses anficity to this family of E3s.
SCF E3 to target a cellular protein for degradation andThe RING finger protein Rbx1 is also a component
contributes to the pathogenesis of AIDS (reviewed inof the VCB-CUL2 E3 complex, which includes the von
Deshaies, 1999). In addition to proteins that use cellularHippel Lindau (VHL) tumor suppressor protein, elongins
E3s, viral genomes encode RING finger proteins that mayC and B and CUL2. VHL mutations that prevent assem-
be E3s themselves. Among these is the Herpes simplexbly of this E3 are associated with the malignancies of
virus-1 (HSV-1) protein, Vmw110/ICP0. Although E3 activ-VHL disease, perhaps due to the stabilization of proteins
ity has not yet been demonstrated for Vmw110, thissuch as hypoxia inducing factor (HIF) 1a. VHL can be
protein targets specific host proteins for proteasomalreplaced in this complex by SOCS box-containing pro-
degradation in a RING finger dependent manner (Everettteins, which, analogous to F-box proteins, presumably
et al., 1999) (Table 1).confer substrate specificity (reviewed in Deshaies, 1999;
The tumor suppressor BRCA1 provides an exampleTyers and Jorgensen, 2000).
where loss of RING finger function is potentially associ-RING finger E3s can influence the balance between
ated with dysregulated growth and malignancy. BRCA1proliferation and apoptosis. Mdm2 binds p53 through
mediates its own ubiquitination in vitro, and although inits N terminus and ubiquitinates p53 and itself, targeting
vivo activity is yet to be demonstrated, mutations inboth to proteasomes. Notably, Mdm2 binds the p53-like
its N-terminal RING finger are associated with familialmolecule p73 in a similar fashion to p53, but does not
breast and ovarian cancer. The BRCA1 RING finger alsotarget p73 for proteasomal degradation. Additionally,
mediates interaction with another RING finger protein,Mdm2 bearing a heterologous RING finger mediates its
BARD1, and with a deubiquitinating enzyme. It remainsown ubiquitination in vitro and targets itself for degrada-
to be determined whether E3 activity is critical fortion in vivo but does not ubiquitinate p53 in vitro or
BRCA1’s role in DNA repair. In yeast, post-replicativetarget it to proteasomes in cells (Fang et al., 2000 and
DNA repair involves two RING finger proteins, Rad18preferences therein). Together these observations sug-
and Rad5p, which physically associate through regionsgest RING specificity in the ubiquitination of heterolo-
outside of their RINGs. Rad18p binds Rad6p whilegous substrates. The activity of RING finger proteins
Rad5p binds Ubc13p, which in turn physically and func-
can also contribute to apoptosis. The observation that tionally interacts with a non-canonical E2-like protein,
proteasome inhibitors block apoptosis led to the deter- Mms2p. Epistasis analyses implicate these proteins in
mination that the RING finger-containing Inhibitors of a common DNA repair pathway. Thus, this E2-RING
Apoptosis (IAPs) are degraded in a proteasome-depen- complex in yeast and their mammalian analogs/homo-
dent manner in response to apoptotic stimuli, and that logs may target specific proteins for ubiquitination at
they undergo RING-dependent auto-ubiquitination in sites of DNA damage (Ulrich and Jentsch, 2000).
vitro and in cells. The stability of RING finger-deficient The finding that mutations in Parkin are associated
forms correlates with enhanced survival. Thus, in re- with Juvenile familial Parkinson’s disease establishes
sponse to apoptotic stimuli the E3 activity of IAPs leads an association of RING finger protein function with a
to their auto-ubiquitination, degradation, and progres- genetic neurodegenerative disorder. Parkin contains an
sion toward cell death (Yang et al., 2000). N-terminal Ub-like domain with its C-terminal half in-
Ubiquitination plays important roles in regulating lev- cluding two atypical RING finger sequences. Parkin as-
els of plasma membrane proteins both through protea- sociates with UbcH7 in a RING finger-dependent manner.
somal degradation and by facilitating endocytosis and When expressed in, and purified from, a neuroblastoma
lysosomal/vacuolar targeting of transmembrane pro- cell line, but not fibroblasts, Parkin co-purifies with ubiq-
teins. The means by which Ub influences protein traffick- uitinated species and mediates in vitro ubiquitination.
ing in the endocytic pathway remains obscure, but multi- The factors that allow for ubiquitination in specific ly-
Ub chains may not be required. RPTKs are ubiquitinated sates, and the nature of the ubiquitinated species now
in response to activating stimuli and degraded primarily become of great interest (Shimura et al., 2000).
in lysosomes. A molecular basis for RPTK ubiquitination Regulation of RING Finger E3s
has now been provided with the determination that pro- There are several examples where phosphorylation
teins of the Cbl family target activated RPTKs for ubiqui- plays regulatory roles in E3 function. The F box compo-
tination in a RING-dependent manner. Cbl-dependent nent of SCF E3s selectively binds phosphorylated sub-
ubiquitination correlates with trafficking to lysosomes strates, and phosphorylation of Mdm2 inhibits p53 bind-
ing. Phosphorylation of c-Cbl is neither required for it toand the termination of signaling. These observations
Cell
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mediate ubiquitination, nor to bind the EGF-R. However, where databases provide us with a large number of
mutation of a tyrosine (Tyr) in the vicinity of the c-Cbl candidate E3s awaiting characterization. Each has the
RING abolishes EGF-R ubiquitination. It has been sug- potential to help us understand how cells orchestrate
gested that phosphorylation at this site may promote a the complexities of rapidly regulating protein levels and
conformational change required for ubiquitination in the activity.
context of the full molecule (Levkowitz et al., 1999). How-
Selected Readingever, this tyrosine is not readily available to phosphoryla-
tion according to the c-Cbl SH2-RING structure (Zheng
Buschmann, T., Fuchs, S.Y., Lee, C.-G., Pan, Z.-Q., and Ronai, Z.et al., 2000).
(2000). Cell 101, 753–762.For Mdm2, protein–protein interactions clearly affect
Deshaies, R.J. (1999). Annu. Rev. Cell Dev. Biol. 15, 435–467.E3 activity. Binding of ARF by Mdm2 exposes a nucleolar
Everett, R.D., Earnshaw, W.C., Findlay, J., and Lomonte, P. (1999).localization signal in the Mdm2 RING, leading to its com-
EMBO J. 18, 1526–1538.partmental segregation from p53. ARF also inhibits
Fang, S., Jensen, J.P., Ludwig, R.L., Vousden, K.H., and Weissman,Mdm2’s intrinsic E3 activity, perhaps through a confor-
A.M. (2000). J. Biol. Chem. 275, 8945–8951.mational change in the RING finger, and as a result both
Freemont, P.S. (2000). Curr. Biol. 2000, R84–R87.p53 and Mdm2 are stabilized. Mdm2’s activity is also
Gmachl, M., Gieffers, C., Podtelejnikov, A.V., Mann, M., and Peters,inhibited by dimerization with its close relative MdmX
J.M. (2000). Proc. Natl. Acad. Sci. USA 97, 8973–8978.through their RING fingers. A number of other RING
Hershko, A., and Ciechanover, A. (1998). Annu. Rev. Biochem. 67,finger proteins form hetero- or homodimers including
425–479.BRCA1 and BARD1, c-Cbl, and Siah. The significance
of these interactions to the regulation of ubiquitination Honda, R., and Yasuda, H. (2000). Oncogene 19, 1473–1476.
is unknown. Joazeiro, C.A., Wing, S.S., Huang, H., Leverson, J.D., Hunter, T.,
Modification with the Ub-like molecules Nedd8 and and Liu, Y.C. (1999). Science 286, 309–312.
SUMO-1 can protect proteins from ubiquitination and Leverson, J.D., Joazeiro, C.A., Page, A.M., Huang, H.-k., Hieter, P.,
degradation, as well as regulate localization, activity, and Hunter, T. (2000). Mol. Biol. Cell 11, 2315–2325.
and protein–protein interactions. Modification of the cul- Levkowitz, G., Waterman, H., Ettenberg, S.A., Katz, M., Tsygankov,
lin components of VCB-CUL2 and SCF E3s with Nedd8, A.Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., Lipkowitz,
S., and Yarden, Y. (1999). Mol. Cell 4, 1029–1040.by a Nedd8-specific E2 and Rbx1, has been reported
and its significance demonstrated with the finding that Lorick, K.L., Jensen, J.P., Fang, S., Ong, A.M., Hatakeyama, S., and
Weissman, A.M. (1999). Proc. Natl. Acad. Sci. USA 96, 11364–11369.ubiquitination of IkBa occurs preferentially through as-
sociation with bTrCP SCF complexes containing Nedd8- Read, M.A., Brownell, J.E., Gladysheva, T.B., Hottelet, M., Parent,
modified CUL-1 (Read et al., 2000 and references L.A., Coggins, M.B., Pierce, J.W., Podust, V.N., Luo, R.S., Chau, V.,
and Palombella, V.J. (2000). Mol. Cell. Biol. 20, 2326–2333.therein). IkBa is also a substrate for modification by
SUMO-1, which has been reported to prevent its ubiqui- Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Miino-
shima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., and Suzuki,tination, thereby stabilizing the protein. As with Nedd8
T. (2000). Nat. Genet. 25, 302–305.and Ub, a specific E1 and E2 for SUMO-1 have been
Tyers, M., and Jorgensen, P. (2000). Curr. Opin. Genet. Dev. 10,identified (references in Buschmann et al., 2000).
54–64.Mdm2 mediates its own modification with SUMO-1,
Ulrich, H.D., and Jentsch, S. (2000). EMBO J. 19, 3388–3397.apparently on a Lys within the Mdm2 RING. This Lys has
also been suggested to be a major site for Mdm2 ubiq- Waterman, H., Levkowitz, G., Alroy, I., and Yarden, Y. (1999). J. Biol.
Chem. 274, 22151–22154.uitination. Importantly, SUMO-1 modification of Mdm2
inhibits its auto-ubiquitination while enhancing its ca- Xie, Y., and Varshavsky, A. (1999). EMBO J. 18, 6832–6844.
pacity to ubiquitinate p53 (Buschmann et al., 2000). The Yang, Y., Fang, S., Jensen, J.P., Weissman, A.M., and Ashwell, J.D.
RING finger proteins PML and Siah-1 also interact with (2000). Science 288, 874–877.
the E2 for SUMO-1 (Ubc9). Modification of proteins with Yokouchi, M., Kondo, T., Houghton, A., Bartkiewicz, M., Horne, W.C.,
Ub-like molecules as a means of modulating E3 activity Zhang, H., Yoshimura, A., and Baron, R. (1999). J. Biol. Chem. 274,
will likely be a recurrent regulatory theme. 31707–31712.
Implications and Future Directions Zheng, N., Wang, P., Jeffrey, P.D., and Pavletich, N.P. (2000). Cell
Ubiquitination is a highly regulated and common cellular 102, 533–539.
process with E3s as central players. RING finger proteins
represent the largest class of E3s to date. Whether RING
fingers are primarily modules that mediate ubiquitination
and other protein modifications or if they have other
discrete functions should soon become apparent. Mam-
malian genomes encode hundreds of RING finger pro-
teins. Extrapolating from in vitro studies, we predict that
many of these have the capacity to interact with E2s
and to potentially mediate ubiquitination. It remains to
be determined how many of these will be bona fide E3s
for heterologous substrates, targets for ubiquitination,
or both. The number of potential E3s is further enhanced
by the combinatorial association of certain RING finger
proteins with other proteins that provide docking sites
for substrates.
The field of intracellular protein degradation now leaves
the era where mediators of substrate-specific ubiquitin-
ation were scarce and enters a new and exciting phase
